Stelios Papadopoulos

Track

Insider profile

Currently holds positions in Regulus Therapeutics Inc, Biogen Inc and Exelixis Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 76% 68% 82%
Transactions
13 23% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board Regulus Therapeutics Inc June 11, 2013 -
Independent Chairman of the Board Biogen Inc June 1, 2014 -
Independent Chairman of the Board, Co-Founder Exelixis Inc Jan. 1, 1998 -
Independent Director Biogen Inc July 1, 2008 - June 1, 2014
Independent Director Regulus Therapeutics Inc Jan. 2, 2009 - June 11, 2013
Stelios Papadopoulos's trades of Exelixis Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-13 2025-11-12
US Exelixis Inc (EXEL)
S Sale
31,654 +11.4%
277.94
US$1,997,261 		31,654 +11.4% 277.94 US$1,997,261
2025-11-12 2025-11-12
US Exelixis Inc (EXEL)
PrS Proposed sale
85,481
383.43
US$2,647,990 		85,481 383.43 US$2,647,990
2025-05-16 2025-05-15
US Exelixis Inc (EXEL)
S Sale
38,069 -49.4%
369.87
US$3,532,027 		38,069 -49.4% 369.87 US$3,532,027
2025-05-16 2025-05-15
US Exelixis Inc (EXEL)
S Sale
20,634 -1.6%
44.35
US$915,118 		20,634 -1.6% 44.35 US$915,118
2025-05-15 2025-05-15
US Exelixis Inc (EXEL)
PrS Proposed sale
36,508
44.35
US$1,619,130 		36,508 44.35 US$1,619,130
2024-05-22 2024-05-20
US Exelixis Inc (EXEL)
S Sale
11,437 -0.9%
21.00
US$240,177 		11,437 -0.9% 21.00 US$240,177
2024-05-20 2024-05-20
US Exelixis Inc (EXEL)
PrS Proposed sale
11,437
21.00
US$240,130 		11,437 21.00 US$240,130
2022-02-24 2022-02-22
US Exelixis Inc (EXEL)
S Sale
84,515 -6.5%
19.56
US$1,653,113 		84,515 -6.5% 19.56 US$1,653,113
2021-05-13 2021-05-11
US Exelixis Inc (EXEL)
S Sale
5,473 -0.4%
25.01
US$136,880 		5,473 -0.4% 25.01 US$136,880
2021-05-13 2021-05-11
US Exelixis Inc (EXEL)
S Sale
5,075 -0.4%
25.00
US$126,875 		5,075 -0.4% 25.00 US$126,875
2021-05-13 2021-05-11
US Exelixis Inc (EXEL)
S Sale
10,222 -0.8%
24.95
US$255,039 		10,222 -0.8% 24.95 US$255,039
2020-05-08 2020-05-08
US Exelixis Inc (EXEL)
S Sale
45,000 -4.1%
25.84
US$1,162,800 		45,000 -4.1% 25.84 US$1,162,800
2019-05-08 2019-05-07
B Purchase
370,370 +45.2%
1.08
US$400,000 		370,370 +45.2% 1.08 US$400,000
2019-02-22 2019-02-21
US Exelixis Inc (EXEL)
S Sale
26,250 -2.5%
21.25
US$557,812 		26,250 -2.5% 21.25 US$557,812
2019-01-02 2018-12-28
B Purchase
50,000 +6.4%
1.09
US$54,570 		50,000 +6.4% 1.09 US$54,570
2018-12-28 2018-12-26
B Purchase
90,000 +13.5%
0.95
US$85,878 		90,000 +13.5% 0.95 US$85,878
2017-07-25 2017-07-25
B Purchase
1,000,000 +129.8%
0.91
US$910,000 		1,000,000 +129.8% 0.91 US$910,000
2017-03-23 2017-03-21
B Purchase
200,000 +99.7%
1.20
US$239,800 		200,000 +99.7% 1.20 US$239,800